ICN: Acquires over 5%, or 568,000 shares of radiopharmacy firm Syncor International, according to a recent 13D filing with the SEC. ICN says it has acquired the shares "as an investment" and "has no plans to participate in the management and control of Syncor".
You may also be interested in...
Hospitals will have a large role in success of these treatments, with a high level of teamwork and coordination required between the technical operations team and the commercial teams working in tight time-frames.
The US agency’s 2021 device funding request for $21m above its 2020 budget will be frozen under a continuing resolution, making planning difficult.
Bakul Patel, director of the US agency’s new Digital Health Center of Excellence, tells Medtech Insight he’s looking to hire staff that want to shape the digital health regulatory landscape.